Russia Offers Vaccine To U.S. After President Trump's Virus Diagnosis

Russia announced Sputnik V as the first COVID-19 vaccine, offering to work with the US, which declined. The vaccine showed antibody results in trials but was initially tested on only 76 people. Now in phase three with 40,000 participants, it has attracted global interest. Other vaccines, including those by Moderna and Astra Zeneca, are also in phase three trials.

What was Russia's offer to the US regarding the Sputnik V vaccine?

• To share vaccine technology with US companies

• To provide free vaccines to US citizens

• To collaborate on vaccine distribution

• To conduct joint research on vaccine development

What did the head of the laboratory developing Sputnik V claim about President Trump?

• He was involved in the vaccine's development

• He supported the vaccine's global distribution

• He had already received the vaccine

• He would have avoided illness with the vaccine

How many participants were involved in the initial clinical trials of Sputnik V?

• 500

• 1000

• 40,000

• 76

Which countries have purchased production rights for Sputnik V?

• The second and third countries with the most infections

• The US and Canada

• Brazil and South Africa

• China and India

Which other companies have vaccines in phase three trials?

• BioNTech and CureVac

• Sinovac and Novavax

• Moderna and AstraZeneca

• Pfizer and Johnson & Johnson